https://t.co/ZDjm6wdWEP @bwmol @RolnikDaniel @vincenzoberghel

https://t.co/ZDjm6wdWEP @bwmol @RolnikDaniel @vincenzoberghel

A great start of the weekend with @MalithaPatabend and @nicolemegan_aux publishing their work @SCSMonash @RolnikDaniel @qianfeng

‘People don’t want to talk’: The taboo ‘zombie’ problem in medical science https://t.co/cScp9mh4IP @HelenaTeede @RuiWangMD @MonashUni @jimgthornton

'We have included data from eight randomised controlled trials with a sample of 4,180 women'

'In women with unfavourable cervices, labour induction with low-dose vaginal misoprostol and vaginal dinoprostone offer comparable effectiveness and perinatal safety.'

'To conclude: Low-dose vaginal misoprostol is likely to lead to a lower rate of composite adverse maternal outcomes than vaginal dinoprostone.'

If you want to learn more about this work, you can check out the authors insights below and access the full paper at the start of this Tweetorial:

Researchers from @SCSMonash discuss their work on Vaginal misoprostol versus vaginal dinoprostone for cervical ripening and induction of labour published in @BJOGTweets this month - check out their Tweetorial below. 👇👇👇 https://t.co/7B5QUbxLtX @bwmol @RolnikDaniel

First author of this work @MalithaPatabend explained 'Misoprostol and dinoprostone are the two main tablet forms available to induce labour. This study which involved a meta-analysis of individual patient data is the most robust research comparing these two methods.'

Vaginal misoprostol versus vaginal dinoprostone for cervical ripening and induction of labour: An individual participant data meta‐analysis of randomised controlled trials

https://t.co/sueyF8qOW6